Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Markus Siegelin"'
Autor:
Qiyu Cao, Annika Hajosch, Richard Kast, Michal Hlavac, Mike-Andrew Westhoff, Markus Siegelin, Christian Rainer Wirtz, Marc-Eric Halatsch, Georg Karpel-Massler
Publikováno v:
Neuro-Oncology. 24:vii225-vii226
OBJECTIVE Drug repurposing represents a promising strategy to safely accelerate the clinical use of therapeutics with antineoplastic activity. In this study, we examined whether Tumor Treating Fields (TTFields) enhance the biological effects of CUSP9
Autor:
Antonia Spilz, Annika Hajosch, Felix Seyfried, Aurelia Peraud, Varun V Prabhu, Joshua E Allen, Mike-Andrew Westhoff, Markus Siegelin, Christian Rainer Wirtz, Georg Karpel-Massler
Publikováno v:
Neuro-Oncology. 24:vii229-vii229
OBJECTIVE Medulloblastoma represents one of the most common brain tumors in children. In this study, we identified by BH3 profiling that ONC201/TIC10 sensitizes for Bcl-xL/Bcl-2 inhibition in medulloblastoma and performed a preclinical testing of a c
Autor:
Trang Nguyen, Enyuan Shang, Chang Shu, Hasan Akman, Benjamin Izar, Mike-Andrew Westhoff, Georg Karpel-Massler, Jeffrey Bruce, Peter Canoll, Markus Siegelin
Publikováno v:
Neuro-Oncology. 24:vii270-vii270
CDK7 has been identified as a potential drug target for glioblastoma (GBM), a highly lethal primary brain tumor. However, resistance to therapy develops quickly, which may be facilitated by drug-induced reprogramming of metabolism. By combination of
Autor:
Davide Tosin, Dominik Schlotter, Annika Hajosch, Michal Hlavac, Mike-Andrew Westhoff, Markus Siegelin, Christian Rainer Wirtz, Georg Karpel-Massler
Publikováno v:
Neuro-Oncology. 24:vii220-vii220
OBJECTIVE A cellular homeostasis that is shifted away from apoptosis and a reprogramming of the lipid metabolism are both, features that are frequently encountered in glioblastoma. This study aimed at investigating whether interference with the lipid
Autor:
Trang Nguyen, Enyuan Shang, Consuelo Torrini, Chang Shu, Mike-Andrew Westhoff, Georg Karpel-Massler, Markus Siegelin
Publikováno v:
Neuro-Oncology. 24:vii270-vii270
Glioblastoma (GBM) remains an incurable disease, requiring more effective therapies. Through CRISPR and RNAi library screening interrogation we identified several TCA-cycle enzymes as essential for GBM growth. By combining a transcriptome and metabol
Autor:
Jana Biermann, Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay A. Caprio, Alcida Karz, Somnath Tagore, Irving Barrera, Miguel A. Ibarra-Arellano, Massimo Andreatta, Benjamin T. Fullerton, Kristjan H. Gretarsson, Varun Sahu, Vaibhav S. Mangipudy, Trang T.T. Nguyen, Ajay Nair, Meri Rogava, Patricia Ho, Peter D. Koch, Matei Banu, Nelson Humala, Aayushi Mahajan, Zachary H. Walsh, Shivem B. Shah, Daniel H. Vaccaro, Blake Caldwell, Michael Mu, Florian Wünnemann, Margot Chazotte, Simon Berhe, Adrienne M. Luoma, Joseph Driver, Matthew Ingham, Shaheer A. Khan, Suthee Rapisuwon, Craig L. Slingluff, Thomas Eigentler, Martin Röcken, Richard Carvajal, Michael B. Atkins, Michael A. Davies, Albert Agustinus, Samuel F. Bakhoum, Elham Azizi, Markus Siegelin, Chao Lu, Santiago J. Carmona, Hanina Hibshoosh, Antoni Ribas, Peter Canoll, Jeffrey N. Bruce, Wenya Linda Bi, Praveen Agrawal, Denis Schapiro, Eva Hernando, Evan Z. Macosko, Fei Chen, Gary K. Schwartz, Benjamin Izar
Publikováno v:
Cell
Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma, yet our understanding of the underlying salient biology is rudimentary. Here, we performed single-cell/nucleus RNA-seq in 22 treatment-naïve MBM and 10 extracrania
Autor:
Markus Siegelin
Publikováno v:
Cryobiology. 81:223